Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang, Jonathan Harris, Richard Wheeler et al. · New England Journal of Medicine · 2010 · 6.5K citations · Full text

Medicine, Oncology, Carcinogenesis +9

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

James A. Bonner, Paul M. Harari, J. Giralt et al. · New England Journal of Medicine · 2006 · 5.1K citations · Full text

Medicine, Oncology, Radiation Oncology +13

Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

Arlene A. Forastiere, Helmuth Goepfert, Moshe Maor et al. · New England Journal of Medicine · 2003 · 3.2K citations · Full text

Medicine, Otolaryngology, Surgery +11

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

Jean‐Pierre Pignon, Aurélie Le Maître, E. Maillard et al. · Radiotherapy and Oncology · 2009 · 3K citations

Medicine, Oncology, Pharmacotherapy +9

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

James A. Bonner, Paul M. Harari, J. Giralt et al. · The Lancet Oncology · 2009 · 2K citations

Medicine, Oncology, Radiation Oncology +13